Skip to content

Scholar Rock SRRK RD Expense Srk181 — Research And Development Expense

Other product segments

Apitegromab
$20.26M
RD Expense Srk439
$1.76M
Early Research
$1.21M-16.8%

Similar metrics at other companies

Tango Therapeutics logo
TNGXPersonnel-Related Expenses-RD — Research And Development Expense
$12.93M-6.6%
Tango Therapeutics logo
TNGXFacilities And Other Related Expenses-RD — Research And Development Expense
$4.34M-20.6%
Tango Therapeutics logo
TNGXDiscovery Direct Program Expenses-RD — Research And Development Expense
$1.87M-60.0%
Dianthus Therapeutics logo
DNTHOther Costs — Research And Development Expense
$1.49M+25.5%
Dianthus Therapeutics logo
DNTHDiscovery Expenses — Research And Development Expense
$1.36M+51.4%
Tango Therapeutics logo
TNGXTNG456Direct Program Expenses-RD — Research And Development Expense
$2.06M+55.8%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's rd expense srk181 — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's RD expense srk181 — research and development expense?
Scholar Rock (SRRK) reported RD expense srk181 — research and development expense of $36K in Q1 2026.
How has Scholar Rock's RD expense srk181 — research and development expense changed year-over-year?
Scholar Rock's RD expense srk181 — research and development expense decreased by 96.8% year-over-year, from $1.11M to $36K.
What does RD expense srk181 — research and development expense mean?
This metric represents the total operating costs directly attributable to the research and development activities for the SRK-181 product candidate. It captures the investment intensity required to advance this specific therapeutic program through preclinical and clinical development stages. Monitoring this expense helps investors assess the company's capital allocation strategy and the progress of its pipeline toward potential regulatory milestones.